Vasalgel: Building the right team
With a year of animal efficacy studies done on Vasalgel male contraceptive, we’ve demonstrated its feasibility — and it’s time to build momentum! But it
With a year of animal efficacy studies done on Vasalgel male contraceptive, we’ve demonstrated its feasibility — and it’s time to build momentum! But it
A LOT of men (and their partners) are waiting eagerly for news of the clinical trials of Vasalgel. It’s getting closer! Over the next six
World Vasectomy Day is an educational event to promote greater understanding and participation by men in family planning. A number of educational events took place on
A history of male contraceptive development – as experienced and related by our founder Elaine Lissner – was recently covered in a Priceonomics article called “The
The Telegraph announced that only one in 10 British men would take a male birth control pill when it is available. This finding is opposite
The publication on a study addressing treatment for enlarged prostate sponsored by Parsemus Foundation is one of the highest ranked articles in The Prostate. Due to
A recent study on dogs offers hope for treating enlarged prostate (technically known as benign prostatic hyperplasia or BPH). Recently published in the online version of The Prostate, researchers
The Medical Daily published a comprehensive news article on the development of male contraceptives, highlighting Vasalgel’s journey to market. Journalist Stephanie Castillo interviewed Parsemus Foundation’s
Evidence is mounting that hormone therapy (HT) after menopause is not associated with increased risks, despite earlier concerns. A recent meta-analysis of a number of
The topic of male contraception was covered in an article by Kristen Fawcett for US News and World Report. Vasalgel and Clean Sheets Pill were
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: